Showing results (221-230 of 297) with videos related to

Sort By:
Pageof 30
Clinical Journal of the American Society of Nephrology : CJASN|January 12, 2024
Phase 2 Trial of Cemdisiran in Adult Patients with IgA Nephropathy: A Randomized Controlled TrialJonathan Barratt, Adrian Liew, See Cheng Yeo, et al.
The New England Journal of Medicine|October 25, 2024
Alternative Complement Pathway Inhibition with Iptacopan in IgA NephropathyVlado Perkovic, Jonathan Barratt, Brad Rovin, et al.
The American Journal of Pathology|July 29, 2015
Role of platelet-derived growth factor-CC in capillary rarefaction in renal fibrosisPeter Boor, Janka Bábíčková, Floor Steegh, et al.
Kidney International|May 26, 2020
After ten years of follow-up, no difference between supportive care plus immunosuppression and supportive care alone in IgA nephropathyThomas Rauen, Stephanie Wied, Christina Fitzner, et al.
Kidney International Reports|January 15, 2025
Study Design and Baseline Characteristics of ALIGN, a Randomized Controlled Study of Atrasentan in Patients With IgA NephropathyHiddo J L Heerspink, Meg Jardine, Donald E Kohan, et al.
Kidney International Reports|April 30, 2025
Corrigendum to "Study Design and Baseline Characteristics of ALIGN, a Randomized Controlled Study of Atrasentan in Patients With IgA Nephropathy" [Volume 10, Issue 1, January 2025, Pages 217-226]Hiddo J L Heerspink, Meg Jardine, Donald E Kohan, et al.
Kidney International|March 29, 2024
A phase 2b, randomized, double-blind, placebo-controlled, clinical trial of atacicept for treatment of IgA nephropathyRichard Lafayette, Sean Barbour, Rubeen Israni, et al.
Kidney International|January 22, 2026
Multi-omics analyses reveal the pathogenic role of terminal ileum-derived IgA+β7+ cells in IgA nephropathyXingzi Liu, Lan Wang, Miaomiao Lin, et al.
Journal of Medicinal Chemistry|December 8, 2022
BAY-7081: A Potent, Selective, and Orally Bioavailable Cyanopyridone-Based PDE9A InhibitorDaniel Meibom, Sina Micus, Anna Lena Andreevski, et al.
Kidney International|March 5, 2019
Identification of platelet-derived growth factor C as a mediator of both renal fibrosis and hypertensionClaudia R C van Roeyen, Ina V Martin, Ana Drescher, et al.
Pageof 30